Tourbah, Ayman et al "24-Month-Treatment with-MD1003 (High Doses of Biotin) in Progressive Multiple Sclerosis: Results of the MS-SPI Trial Extension Phase (S49.004)." Neurology 86.16 Supplement (2016): S49.004. Web. 24 Feb. 2021.